These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38964352)

  • 1. Identifying assessment criteria for in vitro studies: a method and item bank.
    Whaley P; Blain RB; Draper D; Rooney AA; Walker VR; Wattam S; Wright R; Hooijmans CR
    Toxicol Sci; 2024 Oct; 201(2):240-253. PubMed ID: 38964352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.
    Zeng X; Zhang Y; Kwong JS; Zhang C; Li S; Sun F; Niu Y; Du L
    J Evid Based Med; 2015 Feb; 8(1):2-10. PubMed ID: 25594108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis.
    Jiu L; Hartog M; Wang J; Vreman RA; Klungel OH; Mantel-Teeuwisse AK; Goettsch WG
    BMJ Open; 2024 Feb; 14(2):e075173. PubMed ID: 38355183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the ASSESS tool: a comprehenSive tool to Support rEporting and critical appraiSal of qualitative, quantitative, and mixed methods implementation reSearch outcomes.
    Ryan N; Vieira D; Gyamfi J; Ojo T; Shelley D; Ogedegbe O; Iwelunmor J; Peprah E
    Implement Sci Commun; 2022 Mar; 3(1):34. PubMed ID: 35346390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement properties of the Dutch-Flemish patient-reported outcomes measurement information system (PROMIS) physical function item bank and instruments: a systematic review.
    Abma IL; Butje BJD; Ten Klooster PM; van der Wees PJ
    Health Qual Life Outcomes; 2021 Feb; 19(1):62. PubMed ID: 33627157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS).
    Zingg W; Castro-Sanchez E; Secci FV; Edwards R; Drumright LN; Sevdalis N; Holmes AH
    Public Health; 2016 Apr; 133():19-37. PubMed ID: 26704633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preferences for the treatment of type 2 diabetes: a scoping review.
    Joy SM; Little E; Maruthur NM; Purnell TS; Bridges JF
    Pharmacoeconomics; 2013 Oct; 31(10):877-92. PubMed ID: 24081453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A scoping review shows that no single existing risk of bias assessment tool considers all sources of bias for cross-sectional studies.
    Kelly SE; Brooks SPJ; Benkhedda K; MacFarlane AJ; Greene-Finestone LS; Skidmore B; Clifford TJ; Wells GA
    J Clin Epidemiol; 2024 Aug; 172():111408. PubMed ID: 38844117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of collaboration within healthcare settings: a systematic review of measurement properties of instruments.
    Walters SJ; Stern C; Robertson-Malt S
    JBI Database System Rev Implement Rep; 2016 Apr; 14(4):138-97. PubMed ID: 27532315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the RTI item bank on risk of bias and precision of observational studies.
    Viswanathan M; Berkman ND
    J Clin Epidemiol; 2012 Feb; 65(2):163-78. PubMed ID: 21959223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a modified Delphi technique to develop a critical appraisal tool for clinical pharmacokinetic studies.
    Soliman ABE; Pawluk SA; Wilby KJ; Rachid O
    Int J Clin Pharm; 2022 Aug; 44(4):894-903. PubMed ID: 35307788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic mapping of existing tools to appraise methodological strengths and limitations of qualitative research: first stage in the development of the CAMELOT tool.
    Munthe-Kaas HM; Glenton C; Booth A; Noyes J; Lewin S
    BMC Med Res Methodol; 2019 Jun; 19(1):113. PubMed ID: 31164084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodology for developing and evaluating the PROMIS smoking item banks.
    Hansen M; Cai L; Stucky BD; Tucker JS; Shadel WG; Edelen MO
    Nicotine Tob Res; 2014 Sep; 16 Suppl 3(Suppl 3):S175-89. PubMed ID: 23943843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and validation of a meta-tool for quality appraisal of public health evidence: Meta Quality Appraisal Tool (MetaQAT).
    Rosella L; Bowman C; Pach B; Morgan S; Fitzpatrick T; Goel V
    Public Health; 2016 Jul; 136():57-65. PubMed ID: 26993202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.